1 / 12

Gamma Knife Market - Global Study on Gamma Knife to 2020

Increasing prevalence of cancer, growing aging population, rising number of initiatives undertaken by various government associations, and advanced features of Gamma Knife systems are major drivers of the global Gamma Knife market. On the other hand, stringent regulatory requirements and prolonged approval time for Gamma Knife systems as well as high cost of implementation and shortage of skilled manpower are some major concerns for the global Gamma Knife market.

addiethomes
Download Presentation

Gamma Knife Market - Global Study on Gamma Knife to 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. GammaKnifeMarket-GlobalStudyonGammaKnife:Asiato HighestGrowthby2020 Witness PersistenceMarketResearch GlobalGammaKnifeMarketWillReachUS$ 651,241.9thousandin2020:Persistence MarketResearch 1 PersistenceMarketResearch

  2. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 PersistenceMarketResearchReleasedNewMarketReport“GlobalMarketStudyonGammaKnife -AsiatoWitnessHighestGrowthby2020,”theglobalGammaKnifemarketisvaluedat USD526,733.2thousandin2014andisexpectedtogrowataCAGRof3.6%from2014to 2020toreachanestimatedvalueofUSD651,241.9thousandin2020. BrowsethefullGlobalMarketStudyonGammaKnife-AsiatoWitnessHighestGrowthby2020 reportathttp://www.persistencemarketresearch.com/market-research/gamma-knife- market.asp Radiationtherapyisaprocedureentailingtheprecisedeliveryofhighdosesofradiationto tumorsandotherrelevantanatomicaltargets.GammaKniferadiosurgeryisamajorformof radiationtherapy.Itismainlyusedtotreatbraintumors,arteriovenousmalformations, trigeminalneuralgia,acousticneuroma,andpituitarytumors.Globally,theGammaKnife marketiswitnessingsignificantgrowthduetoincreasingprevalenceofcancerandobesityand growingagingpopulation.Inaddition,risingnumberofinitiativesundertakenbyvarious governmentassociationsandtheadvancedfeaturesofGammaKnifesystemsarealsodriving thegrowthofthemarket.However,stringentregulatoryrequirementsandprolongedapproval timeforGammaKnifesystemsandhighcostofimplementationandshortageofskilled manpowerinhibitthegrowthofthemarket.TheglobalGammaKnifemarketisanticipatedto growfromanestimatedUSD526,733.2thousandin2014toUSD651,241.9thousandby2020 ataCAGRof3.6%duringtheforecastperiod. InNorthAmerica,theGammaKnifemarketisgrowingduetotherisingincidenceofcancerin theregion.Inaddition,increasedawarenessaboutGammaKnifetechnologyforcancer treatmentisalsoboostingthegrowthofthemarketintheregion.AccordingtoWHO, approximately2.8millionpeoplehadcancer,includingbraincancer,intheU.S.in2000. Moreover,accordingtotheHindawiPublishingCorporation,aninternationaljournalofsurgical oncology,approximately98,000to170,000newbrainmetastasescasesoccureveryyearin NorthAmerica InEurope,increasingprevalenceofcancerisboostingthegrowthoftheGammaKnifemarket intheregion.AccordingtoWHO,Europeaccountsforonlyone-eighthoftheworld’s population.However,theregionrecordsaroundaquarterofglobalcancercases.Several governmentassociations,suchastheWomenAgainstLungCancerinEurope(WALCE)and EuropeanHeadandNecksociety(EHNS),aretryingtoincreaseawarenessaboutbreast cancer,lungcancer,andheadandneckcancerandtheirbrainmetastaseseffectsinEurope. However,AsiarepresentsthefastestgrowingregionintheGammaKnifemarketduetothe riseincancerpatientsinvariouscountriessuchasIndia,China,andJapan.AccordingtoWHO, theoccurrenceofcancerinIndiaandChinaissettoclimbatarateof78%from2013to2030. 2 PersistenceMarketResearch

  3. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 Inaddition,growingagingpopulationisalsosupportingthegrowthoftheGammaKnifemarket intheregion. InLatinAmerica,constructionofmanufacturingandresearchfacilitiesbymanycompaniesis drivingtheGammaKnifemarketinLatinAmerica.Furthermore,thegovernmentsofLatin Americancountrieshaverecognizedthegrowingepidemicofcancerandareactivelydevising severalpatientawarenessprogramstoraiseawarenessofsignsandsymptomsofcancer, includingbraincancers. ElektaAB,VarianMedicalSystems,Inc.,andHokaiaresomeoftheleadingplayersinthe GammaKnifemarket.OthermajorplayersintheGammaKnifemarketincludeHuiheng Medical,Inc.,CyberMedicalCorporationLimited,MasepInfiniGlobal,Inc.,Nordion,Inc.,ET MedicalGroup,andAmericanSharedHospitalServices. TheglobalGammaKnifemarketissegmentedasfollows: GammaKnifemarket,byapplication •BrainMetastases •BrainTumors •TrigeminalNeuralgia •ArteriovenousMalformations •Others GammaKnifemarket,bygeography •NorthAmerica •U.S. •Canada •RestofNorthAmerica •Europe •Germany •France •U.K. •Italy •Spain •RestofEurope •Asia •China •Japan 3 PersistenceMarketResearch

  4. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 •India •RestofAsia •LatinAmerica •Brazil •RestofLatinAmerica •RestoftheWorld(RoW) MarketHistory: Radiationtherapyisaprocedureentailingtheprecisedeliveryofhighdosesofradiationtotumorsand otherrelevantanatomicaltargets.GammaKniferadiosurgeryisamajorformofradiationtherapy.Itis mainlyusedtotreatbraintumors,arteriovenousmalformations,trigeminalneuralgia,acousticneuroma, andpituitarytumors.InGammaKnifesurgery,specializedequipmentfocusescloseto200tinybeamsof radiationonatumororothertargetedcells.Thesebeamsdeliverstrongdosesofradiationtotargeted tumorcellswithrefinedprecision.Thiseffectivelymeansthatsurroundinghealthytissuesareexposedto minimalornoradiationwhatsoever. Globally,theGammaKnifemarketiswitnessingsignificantgrowthduetoincreasingprevalenceofcancer andobesityandgrowingagingpopulation.Inaddition,risingnumberofinitiativesundertakenbyvarious governmentassociationsandtheadvancedfeaturesofGammaKnifesystemsarealsodrivingthegrowth ofthemarket.However,stringentregulatoryrequirementsandprolongedapprovaltimeforGammaKnife systemsandhighcostofimplementationandshortageofskilledmanpowerinhibitthegrowthofthe market. TheglobalGammaKnifemarketisanticipatedtogrowfromanestimatedUSD526,733.2thousandin 2014toUSD651,241.9thousandby2020ataCAGRof3.6%duringtheforecastperiod. NorthAmericaisthelargestregionandAsiarepresentsthefastestgrowingregionintheGammaKnife market.Intermsofapplication,brainmetastasesrepresentthelargestandfastestgrowingsegmentofthismarket. TheNorthAmericanGammaKnifemarketisanticipatedtogrowfromanestimatedUSD217,115.5 thousandin2014toUSD269,995.5thousandby2020ataCAGRof3.7%duringtheforecastperiod. 4 PersistenceMarketResearch

  5. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 TheglobalbrainmetastasesareestimatedatUSD360,610.2thousandin2014andisexpectedtoreach USD448,903.1thousandby2020,growingataCAGRof3.7%duringtheforecastperiod. TableofContent Chapter1Preface 1.1ReportDescription 1.2ResearchMethodology 1.3Assumptions Chapter2MarketSynopsis Chapter3Porter’sFiveForcesAnalysis 3.1BargainingPowerofSuppliers 3.2BargainingPowerofBuyers 3.3ThreatofNewEntrants 3.4ThreatofSubstitutes 3.5IntensityofRivalry Chapter4IndustryOverview 4.1MarketDefinition 4.2MarketDrivers 4.2.1Increasingprevalenceofcancer 4.2.2Risingagingpopulation 4.2.3Globallyrisingobesity 4.2.4Risingawarenessamongpeopleaboutcancercare 4.2.5AdvancedfeaturesofGammaKnife 4.3ImpactAnalysisofMarketDrivers 4.4MarketRestraints 4.4.1StrictregulatoryrequirementsandlongapprovaltimeforGammaKnifesystems 4.4.2Highcostofimplementationandshortageofskilledmanpower 4.5ImpactAnalysisofMarketRestraints 4.6MarketTrends 5 PersistenceMarketResearch

  6. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 4.6.1IncreasingusageofstereotacticradiationtherapyisgainingpopularityinGammaKnife market Chapter5GlobalMarketSizeandForecast Chapter6MarketSizeandForecastbyApplication 6.1BrainMetastases 6.2BrainTumors 6.3TrigeminalNeuralgia 6.4ArteriovenousMalformations Chapter7MarketSizeandForecastbyGeography 7.1NorthAmerica 7.1.1ScenariointheU.S. 7.1.2ScenarioinCanada 7.2Europe 7.2.1ScenarioinGermany 7.2.2ScenarioinFrance 7.2.3ScenariointheU.K. 7.2.4ScenarioinItaly 7.2.5ScenarioinSpain 7.3Asia 7.3.1ScenarioinChina 7.3.2ScenarioinIndia 7.3.3ScenarioinJapan 7.4LatinAmerica 7.4.1ScenarioinBrazil Chapter8CompetitiveScenario 8.1CompetitiveBenchmarking 6 PersistenceMarketResearch

  7. GammaKnifeMarket-Global HighestGrowthby2020 Study on Gamma Knife : Asia to Witness Chapter9CompanyProfiles 9.1ElektaAB 9.1.1Companyoverview 9.1.2Productsandservices 9.1.3Financialperformance 9.1.4Keydevelopments 9.2VarianMedicalSystems,Inc. 9.2.1Companyoverview 9.2.2Productsandservices 9.2.3Financialperformance 9.2.4Keydevelopments 9.3HuihengMedical,Inc. 9.3.1Companyoverview 9.3.2Productsandservices 9.3.3Financialperformance 9.3.4Keydevelopments 9.4CyberMedicalCorporationLimited 9.4.1Companyoverview 9.4.2Productsandservices 9.4.3Financialperformance 9.4.4Keydevelopments 9.5MasepInfiniGlobal,Inc. 9.5.1Companyoverview 9.5.2Productsandservices 9.5.3Financialperformance 9.5.4Keydevelopments 9.6Nordion,Inc. 9.6.1Companyoverview 9.6.2Productsandservices 9.6.3Financialperformance 9.6.4Keydevelopments 9.7Hokai 7 PersistenceMarketResearch

  8. GammaKnifeMarket-GlobalStudy HighestGrowthby2020 on Gamma Knife : Asia to Witness 9.7.1Companyoverview 9.7.2Productsandservices 9.7.3Financialperformance 9.7.4Keydevelopments 9.8ETMedicalGroup 9.8.1Companyoverview 9.8.2Productsandservices 9.8.3Financialperformance 9.8.4Keydevelopments 9.9AmericanSharedHospitalServices 9.9.1Companyoverview 9.9.2Productsandservices 9.9.3Financialperformance 9.9.4Keydevelopments ListofTables TABLE1Marketsnapshot:GammaKnifemarket,2014and2020 TABLE2Majortypesofcancercausingdeath,2012 TABLE3DriversforGammaKnifemarket:Impactanalysis TABLE4RestraintsforGammaKnifemarket:Impactanalysis TABLE5GlobalGammaKnifemarketsize,byregion,2010–2013(USDthousand) TABLE6GlobalGammaKnifemarketsize,byregion,2014–2020(USDthousand) TABLE7GlobalGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE8GlobalGammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE9GlobalGammaKnifetreatmentforbrainmetastasesmarketsize,byregion,2010– 2013(USDthousand) TABLE10GlobalGammaKnifetreatmentforbrainmetastasesmarketsize,byregion,2014– 2020(USDthousand) TABLE11GlobalGammaKnifetreatmentforbraintumorsmarketsize,byregion,2010–2013 (USDthousand) TABLE12GlobalGammaKnifetreatmentforbraintumorsmarketsize,byregion,2014–2020 (USDthousand) 8 PersistenceMarketResearch

  9. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 TABLE13GlobalGammaKnifetreatmentfortrigeminalneuralgiamarketsize,byregion,2010 –2013(USDthousand) TABLE14GlobalGammaKnifetreatmentfortrigeminalneuralgiamarketsize,byregion,2014 –2020(USDthousand) TABLE15GlobalGammaKnifetreatmentfor region,2010–2013(USDthousand) TABLE16GlobalGammaKnifetreatmentfor region,2014–2020(USDthousand) TABLE17TheNorthAmericanGammaKnife thousand) TABLE18TheNorthAmericanGammaKnife thousand) arteriovenousmalformationsmarketsize,by arteriovenousmalformationsmarketsize,by marketsize,bycountry,2010–2013(USD marketsize,bycountry,2014–2020(USD TABLE19TheU.S.GammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE20TheU.S.GammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE21TheCanadianGammaKnifemarketsize,byapplication,2010–2013(USD thousand) TABLE22TheCanadianGammaKnifemarketsize,byapplication,2014–2020(USD thousand) TABLE23TheEuropeanGammaKnifemarketsize,bycountry,2010–2013(USDthousand) TABLE24TheEuropeanGammaKnifemarketsize,bycountry,2014–2020(USDthousand) TABLE25TheGermanGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE26TheGermanGammaknifemarketsize,byapplication,2014–2020(USDthousand) TABLE27TheFrenchGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE28TheFrenchGammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE29TheU.K.GammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE30TheU.K.GammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE31TheItalianGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE32TheItalianGammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE33TheSpanishGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE34TheSpanishGammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE35TheAsianGammaKnifemarketsize,bycountry,2010–2013(USDthousand) TABLE36TheAsianGammaKnifemarketsize,bycountry,2014–2020(USDthousand) 9 PersistenceMarketResearch

  10. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 TABLE37TheChineseGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE38TheChineseGammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE39TheIndianGammaKnifemarketsize,byapplication,2010–2013(USDthousand) TABLE40TheIndianGammaKnifemarketsize,byapplication,2014–2020(USDthousand) TABLE41TheJapaneseGammaKnifemarketsize,byapplication,2010– thousand) TABLE42TheJapaneseGammaKnifemarketsize,byapplication,2014– thousand) TABLE43TheLatinAmericanGammaKnifemarketsize,bycountry,2010– thousand) 2013 (USD 2020 (USD 2013 (USD TABLE44TheLatinAmericanKnifemarketsize,bycountry,2014–2020(USDthousand) TABLE45TheBrazilianGammaKnifemarketsize,byapplication, thousand) TABLE46TheBrazilianGammaKnifemarketsize,byapplication, thousand) TABLE47ProductcategoriesofElektaAB TABLE48ProductSegmentsofVarianMedicalSystems,Inc. TABLE49ProductcategoriesofHuihengMedical,Inc. TABLE50ProductcategoriesofCyberMedicalCorporationLimited TABLE51ProductcategoriesofMasepInfiniGlobal,Inc. TABLE52ProductsegmentsofNordion,Inc. TABLE53ProductcategoriesofHokai TABLE54ProductsegmentsofETMedicalGroup TABLE55ProductcategoriesofAmericanSharedHospitalServices 2010 – 2013 (USD 2014 – 2020 (USD ListofFigures FIG.1GammaKnifemarket:Porter’sfiveforcesanalysis FIG.2Majortechniquesusedinradiationtherapy FIG.3ComparisonbetweentreatmentofferedbyGammaKniferadiosurgeryradiosurgery andtraditional FIG.4Agingpopulationinmajorcountries,2000–2050(%shareinthetotalpopulation) 10 PersistenceMarketResearch

  11. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 FIG.5Prevalenceofoverweightandobesemalesaged30yearsandabove,2005and2015 (%) FIG.6Prevalenceofoverweightandobesefemalesaged30yearsandabove,2005and2015 (%) FIG.7GlobalGammaKnifemarketshare,byregion,byvalue,2013 FIG.8GlobalGammaKnifemarketshare,byapplication,byvalue,2013 FIG.9GlobalGammaKnifetreatmentforbrainmetastasesmarketshare,byregion,byvalue, 2013 FIG.10GlobalGammaKnifetreatmentforbraintumorsmarketshare,byregion,byvalue,2013 FIG.11GlobalGammaKnifetreatmentfortrigeminalneuralgiamarketshare,byregion,byvalue,2013 FIG.12GlobalGammaKnifetreatmentforarteriovenousmalformationsmarket region,byvalue,2013 FIG.13TheNorthAmericanGammaKnifemarketshare,bycountry,byvalue,2013 FIG.14TheU.S.GammaKnifemarketshare,byapplication,byvalue,2013 FIG.15TheCanadianGammaKnifemarketshare,byapplication,byvalue,2013 FIG.16TheEuropeanGammaKnifemarketshare,bycountry,byvalue,2013 FIG.17TheGermanGammaKnifemarketshare,byapplication,byvalue,2013 FIG.18TheFrenchGammaKnifemarketshare,byapplication,byvalue,2013 FIG.19TheU.K.GammaKnifemarketshare,byapplication,byvalue,2013 FIG.20TheItalianGammaKnifemarketshare,byapplication,byvalue,2013 FIG.21TheSpanishGammaKnifemarketshare,byapplication,byvalue,2013 FIG.22TheAsianGammaKnifemarketshare,bycountry,byvalue,2013 FIG.23TheChineseGammaKnifemarketshare,byapplication,byvalue,2013 FIG.24TheIndianGammaKnifemarketshare,byapplication,byvalue,2013 FIG.25TheJapaneseGammaKnifemarketshare,byapplication,byvalue,2013 FIG.26TheLatinAmericanGammaKnifemarketshare,bycountry,byvalue,2013 FIG.27TheBrazilianGammaKnifemarketshare,byapplication,byvalue,2013 FIG.28CompetitivelandscapeofGammaKnifemarket,2013 FIG.29ElektaAB’snetsalesandprofit,2012–2014(USDmillion) share, by FIG.30VarianMedicalSystems,Inc.’srevenueandnetearnings,2012–2014(USDmillion) FIG.31Nordion,Inc.’srevenueandnetincome/loss,2011–2013(USDmillion) 11 PersistenceMarketResearch

  12. GammaKnifeMarket-GlobalStudyonGammaKnife:AsiatoWitness HighestGrowthby2020 FIG.32Hokai’srevenueandnetincome,2011–2013(USDmillion) FIG.33AmericanSharedHospitalServices’revenueandnetincome/loss,2011–2013(USD thousand) AboutUs: PersistenceMarketResearchisaglobalmarketresearchfirmspecializing-syndicatedresearch,customresearch,andconsultingservices AtPersistenceMarketResearch(PMR),weareinthebusinessofacceleratingyourbusiness.Asafull- servicemarketresearchfirm,westandcommittedtobringingmoreaccuracyandspeedtoyourbusiness decisions.Fromready-to-purchasemarketresearchreportstocustomizedglobalresearchsolutions,our engagementmodelsarehighlyflexiblewithoutcompromisingonourdeep-seatedresearchvalues. Brieflystated,ourmissionistogiveyouaccesstoforecastsandtrendsanalysesthatputyouonthe pathto profitability. PMR’sServicesGoBeyondGleaningData MostenterprisesbelievethatITanddatabasesareenoughtomakeanaccuratedecision.Whilewedo notdisputethat,considerthis:Howlongdoesittaketomakeanaccurate decision?Westrivetodeliverbothevenwithdemandingdeadlines. andstrategicmillion-dollar ContactUs: AddieThomes 305Broadway 7thFloor,NewYorkCity, NY10007,UnitedStates, USA-CanadaTollFree:800-961-0353 Email:sales@persistencemarketresearch.com Web:http://www.persistencemarketresearch.com Twitter:https://twitter.com/addiethomes Blog:http://persistencemarketresearchblog.wordpress.com/ 12 PersistenceMarketResearch

More Related